Literature DB >> 8117273

Purification and characterization of hepatocyte growth factor (HGF)-converting enzyme: activation of pro-HGF.

K Mizuno1, Y Tanoue, I Okano, T Harano, K Takada, T Nakamura.   

Abstract

Hepatocyte growth factor (HGF) is a heterodimer protein, derived from an inactive single-chain precursor (pro-HGF) by the proteolytic cleavage at Arg-Val site. Using a fluorogenic substrate Ac-Lys-Thr-Lys-Gln-Leu-Arg-MCA corresponding to the sequence around the cleavage site of pro-HGF, HGF-converting enzyme was purified from fetal bovine serum. The enzyme is a heterodimer molecule with an apparent molecular weight of about 90-kDa and is composed of a 65-kDa heavy-chain and a 32-kDa light-chain. The enzyme belongs to the serine-protease family and has an optimal pH around 8. The enzyme preferentially cleaved MCA-substrates containing the processing site of pro-HGF. The purified enzyme converted pro-HGF to a two-chain mature form of HGF. The enzyme-treated pro-HGF had mitogenic activity on primary cultured hepatocytes. Thus, the enzyme is likely to be involved in pro-HGF activation in vivo. The enzyme activity in rat serum was 9-fold higher than that in the plasma. This, together with the heterodimeric structure of the enzyme, suggests that the HGF-converting enzyme is activated by another protease in response to a trigger such as blood coagulation or tissue injury.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8117273     DOI: 10.1006/bbrc.1994.1164

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

Review 1.  Molecular and cellular mechanisms of ectodomain shedding.

Authors:  Kazutaka Hayashida; Allison H Bartlett; Ye Chen; Pyong Woo Park
Journal:  Anat Rec (Hoboken)       Date:  2010-06       Impact factor: 2.064

Review 2.  Hepatocyte growth factor/scatter factor-Met signaling in tumorigenicity and invasion/metastasis.

Authors:  M Jeffers; S Rong; G F Vande Woude
Journal:  J Mol Med (Berl)       Date:  1996-09       Impact factor: 4.599

3.  c-MET expression in myofibroblasts: role in autocrine activation and prognostic significance in lung adenocarcinoma.

Authors:  M Tokunou; T Niki; K Eguchi; S Iba; H Tsuda; T Yamada; Y Matsuno; H Kondo; Y Saitoh; H Imamura; S Hirohashi
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

4.  Regulation of cell surface protease matriptase by HAI2 is essential for placental development, neural tube closure and embryonic survival in mice.

Authors:  Roman Szabo; John P Hobson; Kristina Christoph; Peter Kosa; Karin List; Thomas H Bugge
Journal:  Development       Date:  2009-08       Impact factor: 6.868

5.  Epithelial integrity is maintained by a matriptase-dependent proteolytic pathway.

Authors:  Karin List; Peter Kosa; Roman Szabo; Alexandra L Bey; Chao Becky Wang; Alfredo Molinolo; Thomas H Bugge
Journal:  Am J Pathol       Date:  2009-08-28       Impact factor: 4.307

6.  Hepatocyte growth factor(HGF): a new biochemical marker for acute myocardial infarction.

Authors:  T Sato; T Yoshinouchi; T Sakamoto; H Fujieda; S Murao; H Sato; H Kobayashi; T Ohe
Journal:  Heart Vessels       Date:  1997       Impact factor: 2.037

Review 7.  SheddomeDB: the ectodomain shedding database for membrane-bound shed markers.

Authors:  Wei-Sheng Tien; Jun-Hong Chen; Kun-Pin Wu
Journal:  BMC Bioinformatics       Date:  2017-03-14       Impact factor: 3.169

Review 8.  HGF/c-Met: A Key Promoter in Liver Regeneration.

Authors:  Yang Zhao; Wenling Ye; Yan-Dong Wang; Wei-Dong Chen
Journal:  Front Pharmacol       Date:  2022-03-17       Impact factor: 5.810

9.  Hepatocyte growth factor induces proliferation and differentiation of multipotent and erythroid hemopoietic progenitors.

Authors:  F Galimi; G P Bagnara; L Bonsi; E Cottone; A Follenzi; A Simeone; P M Comoglio
Journal:  J Cell Biol       Date:  1994-12       Impact factor: 10.539

10.  Mammary fibroblast-derived hepatocyte growth factor stimulates growth and morphogenesis of mouse mammary tumor cells in primary culture.

Authors:  M Sasaki; M Nishio; Y Tsukada; J Enami
Journal:  Jpn J Cancer Res       Date:  1998-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.